Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the efficacy and safety of eslicarbazepine acetate for acute manic episodes in Bipolar I Disorder; the study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Bipolar I Disorder | Phase 2 | Status: COMPLETED | Results posted: 2013-08-02